Natco Pharma today said it has launched fixed dose combination of Sofosbuvir-Daclatasvir tablets for the treatment of Hepatitis C under the brand name Hepcinat Plus, in India.The product is a generic fixed dose combination of Sofosbuvir 400 mg and Daclatasvir 60mg tablets, used for the treatment of patients with chronic Hepatitis C virus (HCV) infection, it said in a filing to BSE.The company has launched the drug at a maximum retail price of Rs 17,500 for a bottle of 28 tablets, it added.Shares of Natco Pharma were trading at Rs 792.05 per scrip on BSE, down 1.43 per cent from the previous close.
from The Economic Times https://ift.tt/2z4oqDs
via IFTTT
Post Top Ad
Responsive Ads Here
Monday, July 2, 2018
Natco Pharma launches Hepatitis C drug in India
Tags
# latest orai city
# The Economic Times
Share This
About Orai City
The Economic Times
Marcadores:
latest orai city,
The Economic Times
Subscribe to:
Post Comments (Atom)
Post Bottom Ad
Responsive Ads Here
Author Details
Orai is a city and a municipal board in Jalaun district in the Indian state of Uttar Pradesh. It is the district headquarters for Jalaun District
No comments:
Post a Comment